BMHL vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BMHL's deterministic health score is stable with a Piotroski F-Score of 6/9, indicating moderate financial health, but the absence of an Altman Z-Score limits bankruptcy risk assessment. Despite strong profitability metrics like a 30.26% ROE and low debt/equity of 0.09, the stock appears severely overvalued with a P/E of 73.90 versus a sector average of 20.86 and a Graham Number of just $0.48. Revenue growth is exceptional at 199.3% YoY, but earnings have declined by 43.4%, creating a fundamental disconnect. The technical trend is bearish, price performance over 1Y/3Y/5Y is negative, and insider sentiment is weak at 40/100, collectively signaling caution.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BMHL vs JPM: Head-to-Head Comparison
This page compares Bluemount Holdings Limited (BMHL) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.